Expanding the clinical spectrum and management of Traboulsi syndrome: report on two siblings homozygous for a novel pathogenic variant in


Journal

Ophthalmic genetics
ISSN: 1744-5094
Titre abrégé: Ophthalmic Genet
Pays: England
ID NLM: 9436057

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 22 5 2021
medline: 28 1 2022
entrez: 21 5 2021
Statut: ppublish

Résumé

Traboulsi syndrome is a very rare, syndromic form of ectopia lentis that is potentially sight-threatening at a young age. It is characterized by typical facial, skeletal and ocular signs. Two siblings, born to consanguineous parents, with a clinical phenotype consistent with Traboulsi syndrome, underwent extensive ophthalmic imaging and exome-based genetic testing. Both were treated with unilateral clear lens extraction via a limbal approach. Two siblings, one male and one female, presented with systemic and ocular features consistent with Traboulsi syndrome. Lens subluxation was present in all 4fouraffected eyes, and spontaneous subconjunctival bleb formation was detected in one eye. This eye also showed evidence of keratoconus-related corneal thinning. The clinical diagnosis of Traboulsi syndrome was confirmed molecularly. A homozygous, novel, pathogenic nonsense variant was identified in exon 25 of the We expanded the genetic spectrum of Traboulsi syndrome with a novel frameshift variant in the

Sections du résumé

BACKGROUND
Traboulsi syndrome is a very rare, syndromic form of ectopia lentis that is potentially sight-threatening at a young age. It is characterized by typical facial, skeletal and ocular signs.
MATERIALS AND METHODS
Two siblings, born to consanguineous parents, with a clinical phenotype consistent with Traboulsi syndrome, underwent extensive ophthalmic imaging and exome-based genetic testing. Both were treated with unilateral clear lens extraction via a limbal approach.
RESULTS
Two siblings, one male and one female, presented with systemic and ocular features consistent with Traboulsi syndrome. Lens subluxation was present in all 4fouraffected eyes, and spontaneous subconjunctival bleb formation was detected in one eye. This eye also showed evidence of keratoconus-related corneal thinning. The clinical diagnosis of Traboulsi syndrome was confirmed molecularly. A homozygous, novel, pathogenic nonsense variant was identified in exon 25 of the
CONCLUSIONS
We expanded the genetic spectrum of Traboulsi syndrome with a novel frameshift variant in the

Identifiants

pubmed: 34018898
doi: 10.1080/13816810.2021.1923039
doi:

Substances chimiques

Calcium-Binding Proteins 0
Codon, Nonsense 0
Membrane Proteins 0
Muscle Proteins 0
Mixed Function Oxygenases EC 1.-
ASPH protein, human EC 1.14.11.16

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-499

Auteurs

Tom Van Hoorde (T)

Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.

Fanny Nerinckx (F)

Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.

Elke Kreps (E)

Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.

Dimitri Roels (D)

Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.

Philippe Huyghe (P)

Department of Ophthalmology, AZ Nikolaas, Sint-Niklaas, Belgium.

Mattias Van Heetvelde (M)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Hannah Verdin (H)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Elfride De Baere (E)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Irina Balikova (I)

Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.

Bart P Leroy (BP)

Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Department of Head & Skin, Ghent University, Ghent, Belgium.
Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Center for Cellular & Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH